Skip to main content

Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), biote (BTMD)

Tipranks - Tipranks - Thu Jan 29, 7:12AM CST

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK – Research Report) and biote (BTMD – Research Report) with bullish sentiments.

Claim 50% Off TipRanks Premium

Cytokinetics (CYTK)

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Cytokinetics. The company’s shares closed last Tuesday at $64.01.

According to TipRanks.com, Devarakonda is a 5-star analyst with an average return of 17.2% and a 56.7% success rate. Devarakonda covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, Protagonist Therapeutics, and MBX Biosciences, Inc. ;'>

Cytokinetics has an analyst consensus of Strong Buy, with a price target consensus of $91.62, implying a 44.8% upside from current levels. In a report released yesterday, Barclays also initiated coverage with a Buy rating on the stock with a $87.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

biote (BTMD)

Truist Financial analyst Les Sulewski maintained a Buy rating on biote today. The company’s shares closed last Tuesday at $2.18.

According to TipRanks.com, Sulewski is a 4-star analyst with an average return of 9.1% and a 49.5% success rate. Sulewski covers the Healthcare sector, focusing on stocks such as Collegium Pharmaceutical, Bausch Health Companies, and Amneal Pharmaceuticals. ;'>

Currently, the analyst consensus on biote is a Strong Buy with an average price target of $3.67.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).